Projects per year
Personal profile
Education
- 2016 臺北醫學大學藥學系博士班博士
- 2011 臺北醫學大學藥學系碩士班碩士
- 2009 臺北醫學大學藥學系學士
Experience
- 2026- 臺北醫學大學藥學院藥學系藥物科學學科主任
- 2023- 臺北醫學大學藥物科學學科副教授
- 2022-2023 臺北醫學大學新藥開發研究中心副研究員
- 2021-2022 臺北醫學大學新藥開發研究中心助理研究員
- 2018-2021 臺北醫學大學生技醫藥商品中心助理研究員
- 2016-2018 臺北醫學大學博士後研究員
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 8 Finished
-
合成系列多樣雜環衍生物作為具有抗固態腫瘤及血液腫瘤功效之小分子cdc25抑制劑
Liu, Y.-M. (PI)
8/1/25 → 7/31/26
Project: B - Project of TMU › i - Other (Funded by TMU)
-
Synthesis Series Carbamoyl Benzoic Acid Derivatives as Small Molecules for Calcium Channel Inhibitors Used in the Hnscc Treatment
Liu, Y.-M. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Calcium Release-Activated Calcium (Crac) Channel Inhibitor as Anti-Cancer Agent: Pyridinyl-Benzamide as Core Structure via the Use of Organometallic Coupling in the Synthesis
Liu, Y.-M. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
設計及合成 LSD1/HDAC抑制劑作為抗大腸直腸癌劑
Liu, Y.-M. (PI)
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Selective Hdac Inhibitor with Anti-Fibrosis Effect: Pyridone as Core Structure via the Use of Organometallic Coupling Reaction in the Synthesis of Series Derivatives
Liu, Y.-M. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
A novel quinoid-based CDC25 phosphatase inhibitor against human lung adenocarcinoma across different models
Lai, T. C., Narwanti, I., Sethy, B., Tsai, C. H., Sharma, A., Chang, J. H., Liou, J. P., Liu, Y. M. & Chien, M. H., Oct 2025, In: Biomedicine and Pharmacotherapy. 191, 118470.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (Scopus) -
Zinc Finger Protein 639 Expression Is a Novel Prognostic Determinant in Breast Cancer
Lee, F., Cheng, S. P., Chen, M. J., Huang, W. C., Liu, Y. M., Chang, S. C. & Chang, Y. C., Apr 2025, In: Journal of Breast Cancer. 28, 2, p. 86-98 13 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
An updated patent review of histone deacetylase (HDAC) inhibitors in cancer (2020–present)
Liu, Y. M. & Liou, J. P., 2023, (Accepted/In press) In: Expert Opinion on Therapeutic Patents. 33, 5, p. 349-369 21 p.Research output: Contribution to journal › Review article › peer-review
32 Link opens in a new tab Citations (Scopus) -
Enantioselective Intramolecular Hydroacylation of Alkynes by Rhodium Catalysis through Dynamic Kinetic Resolution
Oonishi, Y., Takagishi, K., Liu, Y. M. & Sato, Y., Oct 24 2023, In: Advanced Synthesis and Catalysis. 365, 20, p. 3432-3437 6 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Erratum: N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling (J. Med. Chem. (2015) 58:16 (6549−6558) DOI: 10.1021/acs.jmedchem.5b00659)
Lai, M. J., Lee, H. Y., Chuang, H. Y., Chang, L. H., Tsai, A. C., Chen, M. C., Huang, H. L., Wu, Y. W., Teng, C. M., Pan, S. L., Liu, Y. M., Mehndiratta, S. & Liou, J. P., May 11 2023, In: Journal of Medicinal Chemistry. 66, 9, p. 6436 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)